vs
Astrana Health, Inc.（ASTH）とMSA Safety Inc（MSA）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $510.9M、MSA Safety Incの約1.9倍）。MSA Safety Incの純利益率が高く（17.0% vs 0.7%、差は16.3%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 2.2%）。MSA Safety Incの直近四半期フリーキャッシュフローが多い（$106.0M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 11.2%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
MSAセーフティ（別名マイン・セーフティ・アプライアンシズ）は米国の安全機器メーカー兼サプライヤーで、建設、軍事、消防、化学、石油・ガス生産など危険を伴う業界向けに製品を供給し、本社はピッツバーグ郊外のクランベリーに所在しています。
ASTH vs MSA — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $510.9M |
| 純利益 | $6.6M | $86.9M |
| 粗利率 | — | 46.9% |
| 営業利益率 | 1.9% | 22.3% |
| 純利益率 | 0.7% | 17.0% |
| 売上前年比 | 42.9% | 2.2% |
| 純利益前年比 | 184.4% | -1.2% |
| EPS（希薄化後） | $0.12 | $2.22 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $510.9M | ||
| Q3 25 | $956.0M | $468.4M | ||
| Q2 25 | $654.8M | $474.1M | ||
| Q1 25 | $620.4M | $421.3M | ||
| Q4 24 | $665.2M | $499.7M | ||
| Q3 24 | $478.7M | $432.7M | ||
| Q2 24 | $486.3M | $462.5M | ||
| Q1 24 | $404.4M | $413.3M |
| Q4 25 | $6.6M | $86.9M | ||
| Q3 25 | $373.0K | $69.6M | ||
| Q2 25 | $9.4M | $62.8M | ||
| Q1 25 | $6.7M | $59.6M | ||
| Q4 24 | $-7.8M | $87.9M | ||
| Q3 24 | $16.1M | $66.6M | ||
| Q2 24 | $19.2M | $72.2M | ||
| Q1 24 | $14.8M | $58.1M |
| Q4 25 | — | 46.9% | ||
| Q3 25 | — | 46.5% | ||
| Q2 25 | — | 46.6% | ||
| Q1 25 | — | 45.9% | ||
| Q4 24 | — | 46.9% | ||
| Q3 24 | — | 47.9% | ||
| Q2 24 | — | 48.2% | ||
| Q1 24 | — | 47.3% |
| Q4 25 | 1.9% | 22.3% | ||
| Q3 25 | 2.0% | 20.1% | ||
| Q2 25 | 3.1% | 18.1% | ||
| Q1 25 | 3.3% | 18.5% | ||
| Q4 24 | 0.1% | 23.5% | ||
| Q3 24 | 5.9% | 21.1% | ||
| Q2 24 | 6.2% | 21.6% | ||
| Q1 24 | 7.5% | 19.4% |
| Q4 25 | 0.7% | 17.0% | ||
| Q3 25 | 0.0% | 14.9% | ||
| Q2 25 | 1.4% | 13.2% | ||
| Q1 25 | 1.1% | 14.1% | ||
| Q4 24 | -1.2% | 17.6% | ||
| Q3 24 | 3.4% | 15.4% | ||
| Q2 24 | 3.9% | 15.6% | ||
| Q1 24 | 3.7% | 14.1% |
| Q4 25 | $0.12 | $2.22 | ||
| Q3 25 | $0.01 | $1.77 | ||
| Q2 25 | $0.19 | $1.59 | ||
| Q1 25 | $0.14 | $1.51 | ||
| Q4 24 | $-0.14 | $2.22 | ||
| Q3 24 | $0.33 | $1.69 | ||
| Q2 24 | $0.40 | $1.83 | ||
| Q1 24 | $0.31 | $1.47 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $165.1M |
| 総負債低いほど良い | — | $580.9M |
| 株主資本純資産 | $779.3M | $1.4B |
| 総資産 | $2.2B | $2.6B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.42× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $165.1M | ||
| Q3 25 | $463.4M | $170.0M | ||
| Q2 25 | $342.1M | $147.0M | ||
| Q1 25 | $260.9M | $170.6M | ||
| Q4 24 | $290.8M | $164.6M | ||
| Q3 24 | $350.3M | $154.4M | ||
| Q2 24 | $327.7M | $146.8M | ||
| Q1 24 | $337.3M | $148.3M |
| Q4 25 | — | $580.9M | ||
| Q3 25 | — | $628.6M | ||
| Q2 25 | — | $679.3M | ||
| Q1 25 | — | $502.1M | ||
| Q4 24 | — | $508.0M | ||
| Q3 24 | — | $554.7M | ||
| Q2 24 | — | $588.2M | ||
| Q1 24 | — | $596.2M |
| Q4 25 | $779.3M | $1.4B | ||
| Q3 25 | $775.5M | $1.3B | ||
| Q2 25 | $765.5M | $1.3B | ||
| Q1 25 | $745.4M | $1.2B | ||
| Q4 24 | $712.7M | $1.1B | ||
| Q3 24 | $704.6M | $1.1B | ||
| Q2 24 | $678.9M | $1.0B | ||
| Q1 24 | $653.5M | $994.8M |
| Q4 25 | $2.2B | $2.6B | ||
| Q3 25 | $2.2B | $2.6B | ||
| Q2 25 | $1.4B | $2.6B | ||
| Q1 25 | $1.3B | $2.2B | ||
| Q4 24 | $1.4B | $2.2B | ||
| Q3 24 | $1.3B | $2.2B | ||
| Q2 24 | $1.3B | $2.2B | ||
| Q1 24 | $1.2B | $2.2B |
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | — | 0.44× | ||
| Q3 24 | — | 0.51× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.60× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $122.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $106.0M |
| FCFマージンFCF / 売上 | -0.6% | 20.8% |
| 設備投資強度設備投資 / 売上 | 0.3% | 3.2% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 1.41× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $295.4M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $122.4M | ||
| Q3 25 | $10.0M | $112.5M | ||
| Q2 25 | $90.9M | $67.2M | ||
| Q1 25 | $16.6M | $61.8M | ||
| Q4 24 | $-10.9M | $107.9M | ||
| Q3 24 | $34.0M | $84.3M | ||
| Q2 24 | $23.2M | $53.3M | ||
| Q1 24 | $6.0M | $50.9M |
| Q4 25 | $-6.0M | $106.0M | ||
| Q3 25 | $7.4M | $100.5M | ||
| Q2 25 | $89.5M | $37.9M | ||
| Q1 25 | $13.6M | $51.0M | ||
| Q4 24 | $-13.5M | $93.5M | ||
| Q3 24 | $31.7M | $70.1M | ||
| Q2 24 | $20.4M | $39.0M | ||
| Q1 24 | $5.6M | $39.7M |
| Q4 25 | -0.6% | 20.8% | ||
| Q3 25 | 0.8% | 21.4% | ||
| Q2 25 | 13.7% | 8.0% | ||
| Q1 25 | 2.2% | 12.1% | ||
| Q4 24 | -2.0% | 18.7% | ||
| Q3 24 | 6.6% | 16.2% | ||
| Q2 24 | 4.2% | 8.4% | ||
| Q1 24 | 1.4% | 9.6% |
| Q4 25 | 0.3% | 3.2% | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 0.2% | 6.2% | ||
| Q1 25 | 0.5% | 2.6% | ||
| Q4 24 | 0.4% | 2.9% | ||
| Q3 24 | 0.5% | 3.3% | ||
| Q2 24 | 0.6% | 3.1% | ||
| Q1 24 | 0.1% | 2.7% |
| Q4 25 | -0.44× | 1.41× | ||
| Q3 25 | 26.69× | 1.62× | ||
| Q2 25 | 9.65× | 1.07× | ||
| Q1 25 | 2.48× | 1.04× | ||
| Q4 24 | — | 1.23× | ||
| Q3 24 | 2.11× | 1.27× | ||
| Q2 24 | 1.21× | 0.74× | ||
| Q1 24 | 0.40× | 0.88× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
MSA
| Americas Segment | $335.2M | 66% |
| International Segment | $175.7M | 34% |
